Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...
Shares of vaccine-makers fell after reports Donald Trump is expected to nominate vaccine sceptic Robert F. Kennedy Jr. to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback